Three-dimensional quantitative imaging of telomeres in buccal cells identifies mild, moderate, and severe Alzheimer's disease patients.

Using three-dimensional (3D) telomeric analysis of buccal cells of 82 Alzheimer's disease (AD) patients and cognitively normal age and gender-matched controls, we have for the first time examined changes in the 3D nuclear telomeric architecture of buccal cells among levels of AD severity based on five 3D parameters: i) telomere length, ii) telomere number, iii) telomere aggregation, iv) nuclear volume, and v) a/c ratio, a measure of spatial telomere distribution. Our data indicate that matched controls have significantly different 3D telomere profiles compared to mild, moderate, and severe AD patients (p < 0.0001). Distinct profiles were also evident for each AD severity group. An increase in telomere number and aggregation concomitant with a decrease in telomere length from normal to severe AD defines the individual stages of the disease (p < 0.0001).

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[2]  Andrew Kertesz,et al.  Diagnosis and treatment of dementia: 2. Diagnosis , 2008, Canadian Medical Association Journal.

[3]  B. Rubiś,et al.  Human telomerase activity regulation , 2010, Molecular Biology Reports.

[4]  C B Harley,et al.  Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. , 1993, American journal of human genetics.

[5]  I McDowell,et al.  Community screening for dementia: the Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. , 1997, Journal of clinical epidemiology.

[6]  A. Amiel,et al.  Telomere aggregates in trisomy 21 amniocytes. , 2009, Cancer genetics and cytogenetics.

[7]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[8]  D. McMahon,et al.  Telomere associations in interphase nuclei: possible role in maintenance of interphase chromosome topology. , 2001, Journal of cell science.

[9]  P. Mölsä,et al.  Survival and cause of death in Alzheimer's disease and multi‐infarct dementia , 1986, Acta neurologica Scandinavica.

[10]  Hans Förstl,et al.  Clinical features of Alzheimer’s disease , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[11]  P. Mölsä,et al.  Long‐term survival and predictors of mortality in Alzheimer's disease and multi‐infarct dementia , 1995, Acta neurologica Scandinavica.

[12]  Hong Gu,et al.  Increased “absence” of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome , 2008, Neuroscience Letters.

[13]  T. de Lange,et al.  Removal of Shelterin Reveals the Telomere End-Protection Problem , 2012, Science.

[14]  I. T. Young,et al.  Characterizing the three‐dimensional organization of telomeres , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[15]  E. Montgomery,et al.  Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis , 2004, Clinical Cancer Research.

[16]  M. Fenech,et al.  Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease , 2008, Mechanisms of Ageing and Development.

[17]  I. T. Young,et al.  Robust nuclear lamina-based cell classification of aging and senescent cells , 2011, Aging.

[18]  Susan M. Resnick,et al.  Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons , 2007, Neurobiology of Aging.

[19]  P. Kruk,et al.  DNA damage and repair in telomeres: relation to aging. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Nazarenko,et al.  High frequency of tissue‐specific mosaicism in Turner syndrome patients , 1999, Clinical genetics.

[21]  S. Gauthier,et al.  Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease , 2008, Canadian Medical Association Journal.

[22]  T. Maeda,et al.  Aging-Associated Alteration of Telomere Length and Subtelomeric Status in Female Patients With Parkinson's Disease , 2012, Journal of neurogenetics.

[23]  M. Gustafsson Surpassing the lateral resolution limit by a factor of two using structured illumination microscopy , 2000, Journal of microscopy.

[24]  T. Cremer,et al.  Three-dimensional arrangements of centromeres and telomeres in nuclei of human and murine lymphocytes , 2004, Chromosome Research.

[25]  J. Cummings,et al.  Telomere shortening in T cells correlates with Alzheimer’s disease status , 2003, Neurobiology of Aging.

[26]  L. Migliore,et al.  Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients , 1999, Cytogenetic and Genome Research.

[27]  E. Epel,et al.  Accelerated Cell Aging in Female APOE-ε4 Carriers: Implications for Hormone Therapy Use , 2013, PloS one.

[28]  R. Bertorelle,et al.  Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers , 2010, British Journal of Cancer.

[29]  Nancy E. Adler,et al.  The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men , 2008, Aging.

[30]  A. Amiel,et al.  Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. , 2009, American journal of obstetrics and gynecology.

[31]  M. Fenech,et al.  Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease. , 2007, Mutagenesis.

[32]  Thierry Fest,et al.  c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Mai,et al.  Dynamic chromosomal rearrangements in Hodgkin’s lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles , 2010, Haematologica.

[34]  L. Schaefer,et al.  Generalized approach for accelerated maximum likelihood based image restoration applied to three‐dimensional fluorescence microscopy , 2001, Journal of microscopy.

[35]  Richard O. Duda,et al.  Pattern classification and scene analysis , 1974, A Wiley-Interscience publication.

[36]  Frank Em Effect of Alzheimer's disease on communication function. , 1994 .

[37]  V. Mohan,et al.  Telomere shortening & metabolic/vascular diseases. , 2007, The Indian journal of medical research.

[38]  G H Joss,et al.  Controlled light exposure microscopy reveals dynamic telomere microterritories throughout the cell cycle , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[39]  J. Watson Origin of concatemeric T7 DNA. , 1972, Nature: New biology.

[40]  N. Samani,et al.  Telomere shortening in atherosclerosis , 2001, The Lancet.

[41]  R. Reddel,et al.  The first molecular details of ALT in human tumor cells. , 2005, Human molecular genetics.

[42]  R K Ward,et al.  Telomere length measurements using digital fluorescence microscopy. , 1999, Cytometry.

[43]  L. Migliore,et al.  Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer’s disease , 1997, Human Genetics.

[44]  S. Mai Initiation of telomere‐mediated chromosomal rearrangements in cancer , 2010, Journal of cellular biochemistry.

[45]  David Kipling,et al.  The end-replication problem , 1997, Nature.

[46]  Thomas Cremer,et al.  Multicolor 3D fluorescence in situ hybridization for imaging interphase chromosomes. , 2008, Methods in molecular biology.

[47]  H. Potter,et al.  Chromosome Missegregation and Trisomy 21 Mosaicism in Alzheimer's Disease , 1999, Neurobiology of Disease.

[48]  E. Epel,et al.  Accelerated telomere shortening in response to life stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. Bapat,et al.  Genomic instability and cancer. , 2003, Current molecular medicine.

[50]  A. Lloyd,et al.  Cell Size Regulation in Mammalian Cells , 2007, Cell cycle.

[51]  S. Mai,et al.  Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin’s Lymphoma , 2013, Cancers.

[52]  T. Cech,et al.  Telomere shortening and loss of self-renewal in dyskeratosis congenita iPS cells , 2011, Nature.

[53]  A. Olovnikov [The immune response and the process of marginotomy in lymphoid cells]. , 1972, Vestnik Akademii meditsinskikh nauk SSSR.

[54]  C. Stewart,et al.  Aging and nuclear organization: lamins and progeria. , 2004, Current opinion in cell biology.

[55]  D. Kidron,et al.  Telomere aggregate formation in placenta specimens of pregnancies complicated with pre-eclampsia. , 2009, Cancer genetics and cytogenetics.

[56]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[57]  I. T. Young,et al.  The nuclear lamina promotes telomere aggregation and centromere peripheral localization during senescence of human mesenchymal stem cells , 2008, Journal of Cell Science.

[58]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[59]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[60]  C. Patterson,et al.  4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia , 2012, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[61]  H. Du,et al.  Dysfunctional telomeres and dyskeratosis congenita. , 2007, Haematologica.

[62]  Y. Garini,et al.  The significance of telomeric aggregates in the interphase nuclei of tumor cells , 2006, Journal of cellular biochemistry.

[63]  Hong Gu,et al.  Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia , 2006, Neurobiology of Aging.

[64]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[65]  S. Mai,et al.  Profiling Three-Dimensional Nuclear Telomeric Architecture of Myelodysplastic Syndromes and Acute Myeloid Leukemia Defines Patient Subgroups , 2012, Clinical Cancer Research.

[66]  T. Vulliamy,et al.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC , 2004, Nature Genetics.

[67]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[68]  Vanessa Taler,et al.  Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review , 2008, Journal of clinical and experimental neuropsychology.

[69]  S. Mai,et al.  Three-Dimensional Telomeric Analysis of Isolated Circulating Tumor Cells (CTCs) Defines CTC Subpopulations. , 2013, Translational oncology.

[70]  T. Lange,et al.  Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .

[71]  W. Thies,et al.  2008 Alzheimer’s disease facts and figures , 2008, Alzheimer's & Dementia.

[72]  T. Maeda,et al.  Effect of Vitamin E Administration on the Elevated Oxygen Stress and the Telomeric and Subtelomeric Status in Alzheimer’s Disease , 2011, Gerontology.